Sorafenib kills liver cancer cells by disrupting SCD1‐mediated synthesis of monounsaturated fatty acids <i>via</i> the ATP‐AMPK‐mTOR‐SREBP1 signaling pathway

Ge Liu(Zhejiang Normal University), Chaomin Sun(Chinese Academy of Sciences), Ruobing Cao(Chinese Academy of Sciences), Shan Kuang(Cold Spring Harbor Laboratory), Ju Wang(Nanjing University), Quancai Peng(Institute of Oceanology)
The FASEB Journal
June 14, 2019
10.1096/fj.201802619rr
Cited by 122

Related Papers

Mesenchymal Stem Cell Migration and Tissue Repair
|Cells|2019|1.1k
Convolutional neural network architectures for predicting DNA–protein binding
|Bioinformatics|2016|555
An Alu Transposition Model for the Origin and Expansion of Human Segmental Duplications
|The American Journal of Human Genetics|2003|443
Uncommon Pyrazoyl-Carboxyl Bifunctional Ligand-Based Microporous Lanthanide Systems: Sorption and Luminescent Sensing Properties
|Inorganic Chemistry|2016|297
The structure and evolution of centromeric transition regions within the human genome
|Nature|2004|196